Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

United Therapeutics Corp

NASDAQ: UTHR · Life Sciences · 48 alerts · CIK 1082554

Share price
$587.88Close, Nov 16
Market cap
$25B
Shares outstanding
42.59MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All United Therapeutics Corp filings on SEC EDGAR ↗

4:34 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $587.00 to $597.33 a share (average $593.52) in 11 transactions, worth $5.64M in total on Nov 12, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.52
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 12, 2026
4:39 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.99
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 11, 2026
4:38 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.57M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.52 to $592.93 a share (average $586.32) in 14 transactions, worth $5.57M in total on Nov 10, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.57M
Shares
9,500
Average price
$586.32
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 10, 2026
4:36 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $944K of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,614 shares of United Therapeutics Corp at $583.80 to $585.63 a share (average $584.59) in 3 transactions, worth $944K in total on Nov 9, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$944K
Shares
1,614
Average price
$584.59
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 9, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.52M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,886 shares of United Therapeutics Corp at $556.52 to $582.79 a share (average $572.69) in 24 transactions, worth $4.52M in total on Nov 9, 2026. Shares held after the trade: 326,057 (-0.5%).

Value
$4.52M
Shares
7,886
Average price
$572.69
Role
Chairperson & CEO
Holding change
-0.5%
Trade date
Nov 9, 2026
4:34 PM ET Form 4
Insider Selling

United Therapeutics Director Christopher Patusky Sells $702K of Stock

Christopher Patusky, Director, sold 1,210 shares of United Therapeutics Corp at $580.00 a share, worth $702K in total on Nov 9, 2026. Shares held after the trade: 2,140 (-36.1%).

Value
$702K
Shares
1,210
Price
$580.00
Role
Director
Holding change
-36.1%
Trade date
Nov 9, 2026
5:42 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.36M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $560.79 to $568.68 a share (average $564.51) in 9 transactions, worth $5.36M in total on Nov 6, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.36M
Shares
9,500
Average price
$564.51
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 6, 2026
4:58 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.17M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,950 shares of United Therapeutics Corp at $593.14 to $602.49 a share (average $597.75) in 8 transactions, worth $1.17M in total on Nov 5, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$1.17M
Shares
1,950
Average price
$597.75
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 5, 2026
4:55 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.33M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,540 shares of United Therapeutics Corp at $562.51 to $591.54 a share (average $573.89) in 24 transactions, worth $4.33M in total on Nov 5, 2026. Shares held after the trade: 326,403 (-0.0%).

Value
$4.33M
Shares
7,540
Average price
$573.89
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 5, 2026
5:22 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $1.05M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,723 shares of United Therapeutics Corp at $610.29 to $613.13 a share (average $611.06) in 4 transactions, worth $1.05M in total on Nov 4, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$1.05M
Shares
1,723
Average price
$611.06
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 4, 2026
5:21 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.66M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,777 shares of United Therapeutics Corp at $580.70 to $609.09 a share (average $599.64) in 24 transactions, worth $4.66M in total on Nov 4, 2026. Shares held after the trade: 326,166 (-0.4%).

Value
$4.66M
Shares
7,777
Average price
$599.64
Role
Chairperson & CEO
Holding change
-0.4%
Trade date
Nov 4, 2026
5:15 PM ET Form 4
Insider Selling

United Therapeutics EVP & General Counsel Paul A. Mahon Sells $4.97M of Stock

Paul A. Mahon, EVP & General Counsel, sold 8,300 shares of United Therapeutics Corp at $593.90 to $602.72 a share (average $598.67) in 9 transactions, worth $4.97M in total on Nov 5, 2026. Shares held after the trade: 45,172 (-2.4%).

Value
$4.97M
Shares
8,300
Average price
$598.67
Role
EVP & General Counsel
Holding change
-2.4%
Trade date
Nov 5, 2026
4:39 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.72M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $598.68 to $605.97 a share (average $601.92) in 8 transactions, worth $5.72M in total on Nov 3, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.72M
Shares
9,500
Average price
$601.92
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 3, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.66M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $593.09 to $598.84 a share (average $596.22) in 7 transactions, worth $5.66M in total on Nov 2, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.66M
Shares
9,500
Average price
$596.22
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 2, 2026
4:34 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.7M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $594.92 to $608.05 a share (average $600.09) in 13 transactions, worth $5.7M in total on Oct 30, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.7M
Shares
9,500
Average price
$600.09
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 30, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.65M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $590.43 to $599.30 a share (average $594.78) in 9 transactions, worth $5.65M in total on Oct 29, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.65M
Shares
9,500
Average price
$594.78
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 29, 2026
4:30 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.56M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $583.50 to $588.39 a share (average $585.49) in 6 transactions, worth $5.56M in total on Oct 28, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.56M
Shares
9,500
Average price
$585.49
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 28, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.58M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $582.66 to $592.84 a share (average $587.73) in 11 transactions, worth $5.58M in total on Oct 27, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.58M
Shares
9,500
Average price
$587.73
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 27, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.59M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $585.71 to $592.92 a share (average $588.64) in 8 transactions, worth $5.59M in total on Oct 26, 2026. Shares held after the trade: 324,443 (-0.2%).

Value
$5.59M
Shares
9,500
Average price
$588.64
Role
Chairperson & CEO
Holding change
-0.2%
Trade date
Oct 26, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.54M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.68 to $588.00 a share (average $582.76) in 11 transactions, worth $5.54M in total on Oct 23, 2026. Shares held after the trade: 324,443 (-0.2%).

Value
$5.54M
Shares
9,500
Average price
$582.76
Role
Chairperson & CEO
Holding change
-0.2%
Trade date
Oct 23, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.54M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $562.97 to $590.40 a share (average $583.38) in 21 transactions, worth $5.54M in total on Oct 22, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.54M
Shares
9,500
Average price
$583.38
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 22, 2026
4:36 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.32M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $552.52 to $566.43 a share (average $560.07) in 14 transactions, worth $5.32M in total on Oct 21, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.32M
Shares
9,500
Average price
$560.07
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 21, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.26M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $546.84 to $563.56 a share (average $553.87) in 17 transactions, worth $5.26M in total on Oct 20, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.26M
Shares
9,500
Average price
$553.87
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Oct 20, 2026
4:36 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.16M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $534.75 to $556.88 a share (average $543.32) in 19 transactions, worth $5.16M in total on Oct 19, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.16M
Shares
9,500
Average price
$543.32
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 19, 2026
4:34 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.08M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $530.48 to $543.85 a share (average $534.66) in 13 transactions, worth $5.08M in total on Oct 16, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.08M
Shares
9,500
Average price
$534.66
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 16, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.19M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $540.48 to $551.50 a share (average $546.65) in 12 transactions, worth $5.19M in total on Oct 15, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.19M
Shares
9,500
Average price
$546.65
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 15, 2026
4:34 PM ET Form 4
Insider Selling

United Therapeutics EVP & General Counsel Paul A. Mahon Sells $4.52M of Stock

Paul A. Mahon, EVP & General Counsel, sold 8,300 shares of United Therapeutics Corp at $541.64 to $546.56 a share (average $544.30) in 6 transactions, worth $4.52M in total on Oct 15, 2026. Shares held after the trade: 45,172 (-1.6%).

Value
$4.52M
Shares
8,300
Average price
$544.30
Role
EVP & General Counsel
Holding change
-1.6%
Trade date
Oct 15, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.13M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $526.07 to $546.00 a share (average $539.99) in 16 transactions, worth $5.13M in total on Oct 14, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.13M
Shares
9,500
Average price
$539.99
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 14, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.18M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $542.76 to $551.49 a share (average $545.52) in 10 transactions, worth $5.18M in total on Oct 13, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.18M
Shares
9,500
Average price
$545.52
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 13, 2026
4:31 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.23M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $548.13 to $554.46 a share (average $550.70) in 7 transactions, worth $5.23M in total on Oct 12, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.23M
Shares
9,500
Average price
$550.70
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Oct 12, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.